Fool.com
The World's Greatest Investing Community
Results 31 - 40 of 608 : Previous 1 2 3 4 5 6 7 8 9 Next
It still has a big bet ahead of it, though.
How much do you love it?
Shrugging Off the Side Effects
Sanofi is looking good, but still faces the loss of Lovenox.
Finding Bargains in an Overheated Market
There's still some great value out there.
Of One-Time Gains and Pipelines
AstraZeneca had some of both during the third quarter.
The Waters Aren't Flowing. Yet.
Thank goodness for cost cutting.
Pfizer's and Merck's Loss Is These Companies' Gain
Too busy integrating to take advantage of additional acquisitions.
3 Tips for a More Secure Retirement
You shouldn't need to worry about making ends meet.
A Big Upgrade for Electro-Optical Sciences
This bullish call comes from more than just one analyst.
4-Star Stocks Poised to Pop: Elan
Market-trouncing returns could be written in these four stars.
Legal Information © 1995 - 2009 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK